98 related articles for article (PubMed ID: 12154611)
1. Nonsteroidal anti-inflammatory drugs and potential risks in a convenience sample of general practitioners.
Cutts C; LaCaze A
Aust Fam Physician; 2002 Jun; 31(6):590-2. PubMed ID: 12154611
[TBL] [Abstract][Full Text] [Related]
2. Motivations and perceived influences on rural and urban general practitioners when prescribing conventional non-steroidal anti-inflammatory drugs or COX-2 inhibitors.
Behan K; Cutts C; Tett SE
J Clin Pharm Ther; 2005 Aug; 30(4):337-43. PubMed ID: 15985047
[TBL] [Abstract][Full Text] [Related]
3. Impact of selective cyclooxygenase-2 inhibitors on anti-ulcer medication and non-steroidal anti-inflammatory drug use in patients with rheumatic disease.
Joshua FF; Oakley SP; Major GA
Intern Med J; 2004 Apr; 34(4):153-61. PubMed ID: 15086694
[TBL] [Abstract][Full Text] [Related]
4. Changing perceptions and practices regarding aspirin, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs among US primary care providers.
Elnachef N; Scheiman JM; Fendrick AM; Howden CW; Chey WD
Aliment Pharmacol Ther; 2008 Nov; 28(10):1249-58. PubMed ID: 18729848
[TBL] [Abstract][Full Text] [Related]
5. Gastroprotective drugs in Australia: utilization patterns between 1997 and 2006 in relation to NSAID prescribing.
Barozzi N; Tett SE
Clin Ther; 2009 Apr; 31(4):849-61. PubMed ID: 19446158
[TBL] [Abstract][Full Text] [Related]
6. Long-term NSAID use in primary care: changes over a decade and NICE risk factors for gastrointestinal adverse events.
Thompson PW; Tee L; McBride J; Quincey D; Strat Liddiard G
Rheumatology (Oxford); 2005 Oct; 44(10):1308-10. PubMed ID: 15972345
[TBL] [Abstract][Full Text] [Related]
7. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
[TBL] [Abstract][Full Text] [Related]
8. Minimizing risks of NSAIDs: cardiovascular, gastrointestinal and renal.
Davies NM; Reynolds JK; Undeberg MR; Gates BJ; Ohgami Y; Vega-Villa KR
Expert Rev Neurother; 2006 Nov; 6(11):1643-55. PubMed ID: 17144779
[TBL] [Abstract][Full Text] [Related]
9. What happened to the prescribing of other COX-2 inhibitors, paracetamol and non-steroidal anti-inflammatory drugs when rofecoxib was withdrawn in Australia?
Barozzi N; Tett SE
Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1184-91. PubMed ID: 17636557
[TBL] [Abstract][Full Text] [Related]
10. National trends in cyclooxygenase-2 inhibitor use since market release: nonselective diffusion of a selectively cost-effective innovation.
Dai C; Stafford RS; Alexander GC
Arch Intern Med; 2005 Jan; 165(2):171-7. PubMed ID: 15668363
[TBL] [Abstract][Full Text] [Related]
11. General practitioner prescribing patterns in Babol city, Islamic Republic of Iran.
Moghadamnia AA; Mirbolooki MR; Aghili MB
East Mediterr Health J; 2002; 8(4-5):550-5. PubMed ID: 15603037
[TBL] [Abstract][Full Text] [Related]
12. A Medicare database review found that physician preferences increasingly outweighed patient characteristics as determinants of first-time prescriptions for COX-2 inhibitors.
Schneeweiss S; Glynn RJ; Avorn J; Solomon DH
J Clin Epidemiol; 2005 Jan; 58(1):98-102. PubMed ID: 15649677
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice.
Moore RA; Derry S; Phillips CJ; McQuay HJ
BMC Musculoskelet Disord; 2006 Oct; 7():79. PubMed ID: 17054784
[TBL] [Abstract][Full Text] [Related]
14. Underutilization of preventive strategies in patients receiving NSAIDs.
Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
[TBL] [Abstract][Full Text] [Related]
15. Appropriateness of NSAID and Coxib prescribing for patients with osteoarthritis by primary care physicians in Ontario: results from the CANOAR study.
Sebaldt RJ; Petrie A; Goldsmith CH; Marentette MA
Am J Manag Care; 2004 Nov; 10(11 Pt 1):742-50. PubMed ID: 15623264
[TBL] [Abstract][Full Text] [Related]
16. Nonsteroidal anti-inflammatory drugs in patients with cardio- or cerebrovascular disorders.
Stöllberger C; Finsterer J
Z Kardiol; 2003 Sep; 92(9):721-9. PubMed ID: 14508588
[TBL] [Abstract][Full Text] [Related]
17. Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study.
Depont F; Fourrier A; Merlière Y; Droz C; Amouretti M; Bégaud B; Bénichou J; Moride Y; Velo GP; Sturkenboom M; Blin P; Moore N;
Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):891-900. PubMed ID: 17351983
[TBL] [Abstract][Full Text] [Related]
18. Use of NSAIDs, COX-2 inhibitors, and acetaminophen and associated coprescriptions of gastroprotective agents in an elderly population.
Rahme E; Marentette MA; Kong SX; Lelorier J
Arthritis Rheum; 2002 Dec; 47(6):595-602. PubMed ID: 12522832
[TBL] [Abstract][Full Text] [Related]
19. Orthopaedists' and family practitioners' knowledge of simple low back pain management.
Finestone AS; Raveh A; Mirovsky Y; Lahad A; Milgrom C
Spine (Phila Pa 1976); 2009 Jul; 34(15):1600-3. PubMed ID: 19564770
[TBL] [Abstract][Full Text] [Related]
20. Inadequate prevention of NSAID-induced gastrointestinal events.
Herings RM; Goettsch WG
Ann Pharmacother; 2004 May; 38(5):760-3. PubMed ID: 15031416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]